United Kingdom · Question · Written question
UIN 14115
Parkinson's Disease: Drugs
Introduced
16 February 2024
Last action
27 February 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 February 2024
Summary
To ask the Secretary of State for Health and Social Care, whether she is taking steps with the Medicines and Healthcare products Regulatory Agency to reduce the time taken to license (a) generic and (b) biosimilar medicines to treat Parkinson's disease.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 February 2024
Written question
To ask the Secretary of State for Health and Social Care, whether she is taking steps with the Medicines and Healthcare products Regulatory Agency to reduce the time taken to license (a) generic and (b) biosimilar medicines to treat Parkinson's disease.
Source: Commons
27 February 2024
Answer
The Medicines and Healthcare products Regulatory Agency (MHRA) is taking urgent action to deliver improvements to decision timescales in established medicines, including those indicated to treat Parkinson’s disease. Last week we approved additional licenc...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-02-16/14115
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1689182
- uk · wq-1689182 · source updated 27 February 2024